Ke Li

机构：Hebei General Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-6973-6292

发表论文 71 篇 · 总被引 1105 次 · h-index 18

代表论文

• Mog1 knockout causes cardiac hypertrophy and heart failure by downregulating tbx5‐cryab‐hspb2 signalling in zebrafish (2020 · Acta Physiologica · 被引 22)
• Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response (2025 · Frontiers in Immunology · 被引 20)
• Camrelizumab combined with FOLFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma. (2020 · Journal of Clinical Oncology · 被引 18)
• Boosting humoral and cellular immunity with enhanced STING activation by hierarchical mesoporous metal-organic framework adjuvants (2024 · Journal of Controlled Release · 被引 16)
• Identification of hub genes and pathways associated with cellular senescence in diabetic foot ulcers via comprehensive transcriptome analysis (2023 · Journal of Cellular and Molecular Medicine · 被引 16)
• Glut3 promotes cellular O-GlcNAcylation as a distinctive tumor-supportive feature in Treg cells (2024 · Cellular and Molecular Immunology · 被引 15)